Evidence map›Paper›PMID 40341799›Full record

ArticlePloS one2025

The impact of outpatient settlement for cross-regional medical treatment on healthcare choice by the floating population: PSM+DID evidence based on CFPS.

Qiang Su, Yumeng Zhang, Yuanhao Sui, Lihua Sun, Dawei Zhang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiang SuDepartment of Pharmacy Administration, School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Yumeng ZhangDepartment of Pharmacy Administration, School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Yuanhao SuiDepartment of Pharmacy Administration, School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Lihua SunDepartment of Pharmacy Administration, School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.ORCID https://orcid.org/0009-0001-1705-6313
Dawei ZhangDepartment of Pharmacy Administration, School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The issue of regional disparities in medical resources and insurance benefits is notably prevalent in China. As a result, seeking medical treatment across regions has emerged as a focal point of health reform efforts in recent years. This study examines the impact of outpatient settlement for cross-regional medical treatment on healthcare choices by the floating population who live and work in regions different from their registered residence. Using data from the China Family Panel Studies (CFPS), this study conducts an empirical analysis through Propensity Score Matching and Difference-in-Differences (PSM + DID). The analysis included a sample of 3,019 floating population from 2012 to 2020. The findings indicate that they are significantly more inclined to select advanced medical institution (coefficient = 0.252, p < 0.05) due to the influence of the policy. Furthermore, heterogeneity analysis reveals that this policy primarily affects the labor force (coefficient = 0.268, p < 0.05) and urban residents (coefficient = 0.286, p < 0.05) within the floating population. Ultimately, the outpatient settlement for cross-regional medical treatment affects the floating population to seek care at advanced medical institution, which conflicts with the objectives of the hierarchical medical system. Policymakers should enhance communication to ensure better coordination between these policies.

Indexed as

OutpatientsAdultChinaChoice BehaviorFemaleHealth Services AccessibilityHumansMaleMiddle Aged

Identifiers

PMID40341799
PMCPMC12061399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.